COMPUTED DESCRIPTORS
| Molecular Weight | 1617.8 g/mol |
|---|---|
| XLogP3 | -1.6 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 28 |
| Rotatable Bond Count | 53 |
| Exact Mass | 1616.72078014 g/mol |
| Monoisotopic Mass | 1616.72078014 g/mol |
| Topological Polar Surface Area | 456 Ų |
| Heavy Atom Count | 114 |
| Formal Charge | 0 |
| Complexity | 3190 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Rovalpituzumab Tesirine has been used in trials studying the treatment of GLIOBLASTOMA, Malignant Melanoma, Other Solid Tumors, Small Cell Lung Cancer, and Medullary Thyroid Cancer, among others.